静注用免疫グロブリン市場- 製品別、用途別、流通チャネル別、世界予測、2023年～2032年

世界の静注用免疫グロブリン市場規模は、高齢化人口の増加に牽引され、2023年から2032年にかけて7.6%のCAGRを示す可能性があります。

IMFの予測によると、世界の平均寿命は1913年のわずか34歳から2022年には72歳まで上昇し、目覚ましい進歩を示しており、この上昇傾向は長期的に持続すると予想されています。同様に、『2019年版世界人口見通し』（World Population Prospects）のデータによると、2050年までに世界の65歳以上の高齢者の割合は、2019年の11人に1人（9％）から6人に1人（16％）に増加します。さらに2050年までに、欧州と北アメリカでは4人に1人が65歳以上になる可能性があります。

高齢になると免疫力が低下し、さまざまな病気や症状にかかりやすくなります。IVIGは、様々な自己免疫疾患や免疫不全疾患に対する重要な治療法です。世界的に高齢者人口が増加する中、治療オプションとしてのIVIGに対する需要が増加しており、市場の拡大と成長に有利な環境が整いつつあります。

IgE静注用免疫グロブリン産業は、重篤なアレルギー疾患やアナフィラキシー反応の治療におけるIgE静注用免疫グロブリンの特異的な役割により、2032年までに注目すべき評価を獲得するでしょう。アレルギーが特に先進国で蔓延するにつれて、効果的なアレルギー管理と治療の必要性が高まっています。IgE免疫グロブリンは、生命を脅かすアレルギー反応を経験している人々に的を絞った救済を提供し、重度のアレルギーやアナフィラキシーを管理する上で不可欠な要素となるため、その需要を牽引しています。

重症筋無力症治療におけるIVIGの需要が高く、免疫調節作用があることから、重症筋無力症市場におけるIVIGの市場シェアは、2023年から2032年にかけて顕著な伸びを示すと思われます。重症筋無力症は自己免疫性神経筋疾患であり、免疫系が神経筋接合部を攻撃して筋力低下を引き起こします。IVIG療法は免疫反応を調節し、症状を緩和するのに役立ちます。重症筋無力症のような自己免疫疾患の有病率が上昇を続ける中、治療オプションとしてのIVIGの需要が増加しています。

アジア太平洋地域の静注用免疫グロブリン（IVIG）産業は、複数の要因によって拡大しています。ヘルスケアインフラの増加、IVIG治療に対する認知度の向上、高齢化人口の増加が、同地域の免疫グロブリン製品に対する需要増加に寄与しています。さらに、同地域では自己免疫疾患や免疫不全疾患が急増しており、IVIG治療が必要とされています。ヘルスケアへのアクセスが改善し、認識が広まるにつれて、アジア太平洋地域はIVIG業界に大きな成長機会を提供しています。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 静脈内免疫グロブリン産業洞察

• エコシステム分析
• 業界への影響要因
  • 促進要因
    • 免疫不全疾患の有病率の増加
    • 老人人口の増加
    • 血漿採取、分画、精製技術の進歩の高まり
    • 免疫グロブリンに対するヘルスケア支出の増加
  • 業界の潜在的リスク＆課題
    • IVIG治療の高コスト
    • 副作用やアレルギー反応の可能性
    • 血漿ドナーの不足
• 成長の可能性分析
• COVID-19インパクト分析
• ポーター分析
• PESTEL分析

第4章 競合情勢

• イントロダクション
• 企業マトリックス分析
• 主要市場プレーヤーの競合分析
• 競合のポジショニングマトリックス
• 戦略ダッシュボード

第5章 静注用免疫グロブリン市場規模・予測：製品別

• 主要動向：製品別
• IgG
• IgA
• IgM
• IgD
• IgE

第6章 静注用免疫グロブリン市場規模・予測：用途別

• 主要動向：用途別
• 低ガンマグロブリン血症
• 慢性炎症性脱髄性多発神経炎（CIDP）
• 免疫不全症
• 重症筋無力症
• 多巣性運動ニューロパチー
• 特発性血小板減少性紫斑病（ITP）
• 炎症性ミオパチー
• 特異的抗体欠損症
• ギラン・バレー症候群
• その他の用途

第7章 静注用免疫グロブリン市場規模・予測：流通チャネル別

• 主要動向：流通チャネル別
• 病院薬局
• 専門薬局
• その他の流通チャネル

第8章 静注用免疫グロブリン市場規模・予測：地域別

• 主要動向：地域別
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • その他中東とアフリカ

第9章 企業プロファイル

• Takeda Pharmaceutical Company Limited.
• Grifols SA
• CSL Behring
• ADMA Biologics
• Octapharma AG
• Baxter International Inc.
• LFB Biotechnologies
• China Biologics Products Inc.
• Kedrion Biopharma
• Intas Pharmaceuticals

Data Tables

• TABLE 1. Product mapping
• TABLE 2. Market revenue, by product (2022)
• TABLE 3. Market revenue, by application (2022)
• TABLE 4. Market share, by distribution channel (2022)
• TABLE 5. Market share, by region (2022)
• TABLE 6. Global intravenous immunoglobulin market size, 2018-2022, (USD Million)
• TABLE 7. Global intravenous immunoglobulin market size, 2023-2032, (USD Million)
• TABLE 8. Global intravenous immunoglobulin market size, by region, 2018-2022 (USD Million)
• TABLE 9. Global intravenous immunoglobulin market size, by region, 2023-2032 (USD Million)
• TABLE 10. Global intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 11. Global intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 12. Global intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 13. Global intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 14. Global intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 15. Global intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 16. Industry impact forces
• TABLE 17. IgG market size, 2018-2022 (USD Million)
• TABLE 18. IgG market size, 2023-2032 (USD Million)
• TABLE 19. IgA market size, 2018-2022 (USD Million)
• TABLE 20. IgA market size, 2023-2032 (USD Million)
• TABLE 21. IgM market size, 2018-2022 (USD Million)
• TABLE 22. IgM market size, 2023-2032 (USD Million)
• TABLE 23. IgD market size, 2018-2022 (USD Million)
• TABLE 24. IgD market size, 2023-2032 (USD Million)
• TABLE 25. IgE market size, 2018-2022 (USD Million)
• TABLE 26. IgE market size, 2023-2032 (USD Million)
• TABLE 27. Hypogammaglobulinemia market size, 2018-2022 (USD Million)
• TABLE 28. Hypogammaglobulinemia market size, 2023-2032 (USD Million)
• TABLE 29. Chronic Inflammatory demyelinating polyneuropathy (CIDP) market size, 2018-2022 (USD Million)
• TABLE 30. Chronic Inflammatory demyelinating polyneuropathy (CIDP) market size, 2023-2032 (USD Million)
• TABLE 31. Immunodeficiency diseases market size, 2018-2022 (USD Million)
• TABLE 32. Immunodeficiency diseases market size, 2023-2032 (USD Million)
• TABLE 33. Myasthenia gravis market size, 2018-2022 (USD Million)
• TABLE 34. Myasthenia gravis market size, 2023-2032 (USD Million)
• TABLE 35. Multifocal motor neuropathy market size, 2018-2022 (USD Million)
• TABLE 36. Multifocal motor neuropathy market size, 2023-2032 (USD Million)
• TABLE 37. Idiopathic thrombocytopenic purpura (ITP) market size, 2018-2022 (USD Million)
• TABLE 38. Idiopathic thrombocytopenic purpura (ITP) market size, 2023-2032 (USD Million)
• TABLE 39. Inflammatory myopathies market size, 2018-2022 (USD Million)
• TABLE 40. Inflammatory myopathies market size, 2023-2032 (USD Million)
• TABLE 41. Specific antibody deficiency market size, 2018-2022 (USD Million)
• TABLE 42. Specific antibody deficiency market size, 2023-2032 (USD Million)
• TABLE 43. Guillain-Barre syndrome market size, 2018-2022 (USD Million)
• TABLE 44. Guillain-Barre syndrome market size, 2023-2032 (USD Million)
• TABLE 45. Other applications market size, 2018-2022 (USD Million)
• TABLE 46. Other applications market size, 2023-2032 (USD Million)
• TABLE 47. Hospital pharmacy market size, 2018-2022 (USD Million)
• TABLE 48. Hospital pharmacy market size, 2023-2032 (USD Million)
• TABLE 49. Specialty pharmacy market size, 2018-2022 (USD Million)
• TABLE 50. Specialty pharmacy market size, 2023-2032 (USD Million)
• TABLE 51. Other distribution channels market size, 2018-2022 (USD Million)
• TABLE 52. Other distribution channels market size, 2023-2032 (USD Million)
• TABLE 53. North America intravenous immunoglobulin market size, by country, 2018-2022 (USD Million)
• TABLE 54. North America intravenous immunoglobulin market size, by country, 2023-2032 (USD Million)
• TABLE 55. North America intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 56. North America intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 57. North America intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 58. North America intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 59. North America intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 60. North America intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 61. U.S. intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 62. U.S. intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 63. U.S. intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 64. U.S. intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 65. U.S. intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 66. U.S. intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 67. Canada intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 68. Canada intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 69. Canada intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 70. Canada intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 71. Canada intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 72. Canada intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 73. Europe intravenous immunoglobulin market size, by country, 2018-2022 (USD Million)
• TABLE 74. Europe intravenous immunoglobulin market size, by country, 2023-2032 (USD Million)
• TABLE 75. Europe intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 76. Europe intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 77. Europe intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 78. Europe intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 79. Europe intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 80. Europe intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 81. Germany intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 82. Germany intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 83. Germany intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 84. Germany intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 85. Germany intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 86. Germany intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 87. UK intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 88. UK intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 89. UK intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 90. UK intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 91. UK intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 92. UK intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 93. France intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 94. France intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 95. France intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 96. France intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 97. France intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 98. France intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 99. Italy intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 100. Italy intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 101. Italy intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 102. Italy intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 103. Italy intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 104. Italy intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 105. Spain intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 106. Spain intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 107. Spain intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 108. Spain intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 109. Spain intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 110. Spain intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 111. Rest of Europe intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 112. Rest of Europe intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 113. Rest of Europe intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 114. Rest of Europe intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 115. Rest of Europe intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 116. Rest of Europe intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 117. Asia Pacific intravenous immunoglobulin market size, by country, 2018-2022 (USD Million)
• TABLE 118. Asia Pacific intravenous immunoglobulin market size, by country, 2023-2032 (USD Million)
• TABLE 119. Asia Pacific intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 120. Asia Pacific intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 121. Asia Pacific intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 122. Asia Pacific intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 123. Asia Pacific intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 124. Asia Pacific intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 125. Japan intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 126. Japan intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 127. Japan intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 128. Japan intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 129. Japan intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 130. Japan intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 131. China intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 132. China intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 133. China intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 134. China intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 135. China intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 136. China intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 137. India intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 138. India intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 139. India intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 140. India intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 141. India intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 142. India intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 143. Australia intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 144. Australia intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 145. Australia intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 146. Australia intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 147. Australia intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 148. Australia intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 149. South Korea intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 150. South Korea intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 151. South Korea intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 152. South Korea intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 153. South Korea intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 154. South Korea intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 155. Rest of Asia Pacific intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 156. Rest of Asia Pacific intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 157. Rest of Asia Pacific intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 158. Rest of Asia Pacific intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 159. Rest of Asia Pacific intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 160. Rest of Asia Pacific intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 161. Latin America intravenous immunoglobulin market size, by country, 2018-2022 (USD Million)
• TABLE 162. Latin America intravenous immunoglobulin market size, by country, 2023-2032 (USD Million)
• TABLE 163. Latin America intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 164. Latin America intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 165. Latin America intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 166. Latin America intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 167. Latin America intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 168. Latin America intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 169. Brazil intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 170. Brazil intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 171. Brazil intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 172. Brazil intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 173. Brazil intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 174. Brazil intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 175. Mexico intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 176. Mexico intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 177. Mexico intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 178. Mexico intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 179. Mexico intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 180. Mexico intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 181. Rest of Latin America intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 182. Rest of Latin America intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 183. Rest of Latin America intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 184. Rest of Latin America intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 185. Rest of Latin America intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 186. Rest of Latin America intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 187. Middle East & Africa intravenous immunoglobulin market size, by country, 2018-2022 (USD Million)
• TABLE 188. Middle East & Africa intravenous immunoglobulin market size, by country, 2023-2032 (USD Million)
• TABLE 189. Middle East & Africa intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 190. Middle East & Africa intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 191. Middle East & Africa intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 192. Middle East & Africa intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 193. Middle East & Africa intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 194. Middle East & Africa intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 195. South Africa intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 196. South Africa intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 197. South Africa intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 198. South Africa intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 199. South Africa intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 200. South Africa intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 201. Saudi Arabia intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 202. Saudi Arabia intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 203. Saudi Arabia intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 204. Saudi Arabia intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 205. Saudi Arabia intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 206. Saudi Arabia intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 207. Rest of Middle East & Africa intravenous immunoglobulin market size, by product, 2018-2022 (USD Million)
• TABLE 208. Rest of Middle East & Africa intravenous immunoglobulin market size, by product, 2023-2032 (USD Million)
• TABLE 209. Rest of Middle East & Africa intravenous immunoglobulin market size, by application, 2018-2022 (USD Million)
• TABLE 210. Rest of Middle East & Africa intravenous immunoglobulin market size, by application, 2023-2032 (USD Million)
• TABLE 211. Rest of Middle East & Africa intravenous immunoglobulin market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 212. Rest of Middle East & Africa intravenous immunoglobulin market size, by distribution channel, 2023-2032 (USD Million)

Charts & Figures

• FIG. 1 Industry segmentation
• FIG. 2 Top-down approach
• FIG. 3 Market estimation and forecast
• FIG. 4 Market forecasting methodology
• FIG. 5 Breakdown of primary participants
• FIG. 6 Intravenous immunoglobulin industry, 360 degree synopsis, 2018 - 2032
• FIG. 7 Industry landscape, 2018-2032 (USD Million)
• FIG. 8 Growth potential analysis, by product
• FIG. 9 Growth potential analysis, by application
• FIG. 10 Growth potential analysis, by distribution channel
• FIG. 11 Porter's analysis
• FIG. 12 PESTEL analysis
• FIG. 13 Company matrix analysis, 2022
• FIG. 14 Strategy dashboard, 2022

Global Intravenous Immunoglobulin Market size could exhibit 7.6% CAGR from 2023 to 2032, driven by the rise in the aging population. According to IMF projections, global life expectancy has shown remarkable progress, rising from just 34 years in 1913 to 72 years in 2022, and this upward trend is expected to persist over the long term. Similarly, data from the 2019 Revision of World Population Prospects reveals that by 2050, the proportion of people aged over 65 in the world will increase to one in six (16%), up from one in eleven (9%) in 2019. Furthermore, by 2050, as many as one in four individuals in Europe and Northern America may be 65 or older.

As people age, their immune systems may weaken, making them more susceptible to various diseases and conditions. IVIG is a crucial treatment for various autoimmune and immunodeficiency disorders. With a growing elderly demographic worldwide, the demand for IVIG as a therapeutic option is increasing, creating a favorable environment for market expansion and growth.

The overall Intravenous Immunoglobulin Market is categorized based on product, application, distribution channel, and region.

IgE Intravenous Immunoglobulin Industry will garner a noteworthy valuation by 2032 due to the specific role of IgE Intravenous Immunoglobulin in treating severe allergic conditions and anaphylactic reactions. As allergies become more prevalent, especially in developed nations, there's a growing need for effective allergy management and treatment. IgE immunoglobulin provides targeted relief for those experiencing life-threatening allergic responses, making it a vital component in managing severe allergies and anaphylaxis, thus driving its demand.

Intravenous immunoglobulin market share from the Myasthenia Gravis segment will grow commendably over 2023-2032 due to the high demand for IVIG in the treatment of Myasthenia Gravis owing to its immunomodulatory effects. Myasthenia Gravis is an autoimmune neuromuscular disorder where the immune system attacks neuromuscular junctions, leading to muscle weakness. IVIG therapy helps to modulate the immune response and alleviate symptoms. As the prevalence of autoimmune diseases like Myasthenia Gravis continues to rise, the demand for IVIG as a treatment option has increased.

Asia Pacific intravenous immunoglobulin (IVIG) industry is expanding due to multiple factors. Increasing healthcare infrastructure, rising awareness of IVIG therapies, and a growing aging population have contributed to the region's increased demand for immunoglobulin products. Moreover, a surge in autoimmune and immunodeficiency disorders in the region necessitates IVIG treatment. As healthcare access improves and awareness spreads, the Asia Pacific region offers significant growth opportunities for the IVIG industry.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & calculations
• 1.3 Forecast parameters
• 1.4 COVID-19 impact analysis
• 1.5 Data validation
• 1.6 Data Sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Intravenous immunoglobulin industry 360 degree synopsis, 2018 - 2032
  • 2.1.1 Business trends
  • 2.1.2 Regional trends
  • 2.1.3 Product trends
  • 2.1.4 Application trends
  • 2.1.5 Distribution channel trends

Chapter 3 Intravenous Immunoglobulin Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing prevalence of immunodeficiency disorders
    • 3.2.1.2 Increasing geriatric population
    • 3.2.1.3 Growing advances in plasma collection, fractionation, and purification technologies
    • 3.2.1.4 Increasing healthcare expenditure for immunoglobulins
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of IVIG therapy
    • 3.2.2.2 Potential adverse effects and allergic reactions
    • 3.2.2.3 Scarcity of plasma donors
• 3.3 Growth potential analysis
  • 3.3.1 By product
  • 3.3.2 By application
  • 3.3.3 By distribution channel
• 3.4 COVID- 19 impact analysis
• 3.5 Porter's analysis
• 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Competitive analysis of major market players, 2022
• 4.4 Competitive positioning matrix, 2022
• 4.5 Strategy dashboard, 2022

Chapter 5 Intravenous Immunoglobulin Market Size and Forecast, By Product (USD Million)

• 5.1 Key trends, by product
• 5.2 IgG
• 5.3 IgA
• 5.4 IgM
• 5.5 IgD
• 5.6 IgE

Chapter 6 Intravenous Immunoglobulin Market Size and Forecast, By Application (USD Million)

• 6.1 Key trends, by application
• 6.2 Hypogammaglobulinemia
• 6.3 Chronic Inflammatory demyelinating polyneuropathy (CIDP)
• 6.4 Immunodeficiency diseases
• 6.5 Myasthenia gravis
• 6.6 Multifocal motor neuropathy
• 6.7 Idiopathic thrombocytopenic purpura (ITP)
• 6.8 Inflammatory myopathies
• 6.9 Specific antibody deficiency
• 6.10 Guillain-Barre syndrome
• 6.11 Other applications

Chapter 7 Intravenous Immunoglobulin Market Size and Forecast, By Distribution Channel (USD Million)

• 7.1 Key trends, by distribution channel
• 7.2 Hospital pharmacy
• 7.3 Specialty pharmacy
• 7.4 Other distribution channels

Chapter 8 Intravenous Immunoglobulin Market Size and Forecast, By Region (USD Million)

• 8.1 Key trends, by region
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Rest of Latin America
• 8.6 Middle East & Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 Rest of Middle East & Africa

Chapter 9 Company Profiles

• 9.1 Takeda Pharmaceutical Company Limited.
• 9.2 Grifols SA
• 9.3 CSL Behring
• 9.4 ADMA Biologics
• 9.5 Octapharma AG
• 9.6 Baxter International Inc.
• 9.7 LFB Biotechnologies
• 9.8 China Biologics Products Inc.
• 9.9 Kedrion Biopharma
• 9.10 Intas Pharmaceuticals